This inventor holds 2 USPTO granted patents. Top assignee: Laboratorios Cusi, S.a.. Active years: 1997-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1999
Title: Innovations by Anna Coll Dachs
Introduction
Anna Coll Dachs is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the fields of medicine, pharmacy, and nanotechnology. With a total of 2 patents, her work focuses on enhancing the stability and efficacy of pharmaceutical formulations.
Latest Patents
One of her latest patents is a method to increase the stability of nanocapsules during storage. This innovative method involves adding a monosaccharide cryoprotective agent into the aqueous dispersion of the nanocapsules while maintaining gentle stirring until it dissolves completely. The dispersion is then frozen at a temperature of not less than -40°C for about 2 to 4 hours. Following this, the water is eliminated by progressively heating to a temperature of about 35°C at reduced pressure, resulting in a stable lyophilized product. This product can be conveniently reconstituted by adding water or a more complex aqueous solution. The nanocapsules have applications in medicine, pharmacy, cosmetics, the chemical industry, agriculture, and veterinary science.
Another notable patent is for a pharmaceutical vehicle that is a nanoemulsion, useful as an ophthalmic vehicle. This formulation includes 0.1-10% (w/v) of an oil, 0.1-10% (w/v) of a non-ionic surface active agent, and a maximum of 0.01% (w/v) of benzalkonium chloride, among other components. The vehicle is prepared by emulsifying an aqueous phase containing a non-ionic surface active agent with an organic phase that includes dissolved oil and the drug. This innovative vehicle is particularly beneficial in ophthalmic preparations used to treat eye disorders and diseases.
Career Highlights
Anna works at Laboratorios Cusi, S.A., where she continues to develop her innovative ideas and contribute to the advancement of pharmaceutical technologies. Her work has garnered attention for its potential to improve drug delivery systems and enhance patient outcomes.
Collaborations
She collaborates with notable colleagues, including Nuria Carreras Perdiguer and Francisco Javier Galan Valdivia, to further her research and development efforts.
Conclusion
Anna Coll Dachs is a trailblazer in the field of nanotechnology and pharmaceuticals. Her innovative patents and dedication to improving drug formulations highlight her significant impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile